Veterinary and Comparative Oncology

Article	Citations
Issue Information	22
Serum thymidine kinase 1 activity as a prognostic biomarker in dogs with chemotherapy‐treated diffuse large B‐cell lymphoma	20
High lysyl oxidase expression is an indicator of poor prognosis in dogs with cutaneous mast cell tumours	19
Effects of a high‐protein, increased‐fibre, dry diet supplemented with omega‐3 fatty acids on quality of life in dogs undergoing chemotherapy	18
Ultrasound‐guided core needle biopsy in dogs with thyroid carcinoma	18
Investigation of efficacy of two different chemotherapy protocols used in neoadjuvant chemotherapy in clinical stages II–IV canine malignant mammary tumours	17
Outcomes of 35 dogs with craniomaxillofacial osteosarcoma treated with stereotactic body radiation therapy	16
Timely adjuvant chemotherapy improves outcome in dogs with non‐metastatic splenic hemangiosarcoma undergoing splenectomy	15
There and back again: Translating adoptive cell therapy to canine cancer and improving human treatment	15
Treatment of feline intermediate to high‐grade alimentary lymphoma: A retrospective evaluation of 55 cats treated with the VAPC combination chemotherapy protocol (2017–2021)	14
Polarisation Sensitive Optical Coherence Tomography Image Characteristics for Gastrointestinal Tumours and Normal Tissues at Surgical Margins in Dogs	13
Descriptive analysis of haemangiosarcoma occurrence in dogs enrolled in the Golden Retriever lifetime study	13
Standardisation of canine meningioma grading: Inter‐observer agreement and recommendations for reproducible histopathologic criteria	12
Plasma cell‐free DNA in canine lymphoma patients as a novel material for genotyping	12
Pre‐operative neoadjuvant vinblastine‐prednisolone in canine mast cell tumours: A single‐centre retrospective cohort study	12
Risk factors associated with the onset of lomustine‐induced neutropenia in tumour‐bearing dogs	12
Efficacy and adverse events of continuousl‐asparaginase administration for canine large cell lymphoma of presumed gastrointestinal origin	11
Practice patterns about the role of palliation in veterinary surgical oncology	11
Blood biomarkers for canine cancer, from human to veterinary oncology	11
Dysregulated miRNAs in a canine model of haemangiosarcoma metastatic to the brain	11
Combining radiation therapy with zoledronate for the treatment of osteo‐invasive feline oral squamous cell carcinoma	10
Issue Information	10
Outcome of dogs treated with chemotherapy for mesothelioma: A retrospective clinical study on 40 cases and a literature review	10
	10
Determining agreement between preoperative computed tomography lymphography and indocyanine green near infrared fluorescence intraoperative imaging for sentinel lymph node mapping in dogs with oral tu	10

Expression of Concern: Tumour necrosis factor‐alpha‐induced protein 8 (TNFAIP8) expression associated with cell survival and death in cancer cell lines infected with canine distemper virus	9
Issue Information	9
Author Index	9
Corrigendum	9
Issue Information	9
	9
Efficacy and toxicity of carboplatin in the treatment of macroscopic mesenchymal neoplasia in dogs	8
Cover Image	8
Issue Information	8
Use of Cystourethroscopy to Define the Gross Tumour Volume in Radiation Treatment Planning for Canine Genitourinary Carcinomas	8
	8
Effects of Lipophilic Statins on Cell Viability and Tissue Factor Expression in Canine Haemangiosarcoma Cells	8
Extensive staging has no prognostic value in dogs with low‐risk mast cell tumours	8
Chronic adrenergic stress and generation of myeloid‐derived suppressor cells: Implications for cancer immunotherapy in dogs	8
	8
Epidemiology of canine cutaneous round cell tumours on the canary archipelago in Spain	7
Issue Information	7
Spotlight on capecitabine for the treatment of unresectable or metastatic carcinoma of various origin: A retrospective study of 25 dogs	7
Frontal sinus carcinoma in forty‐one dogs (2001–2022)	7
Classification and Prognostication of B‐Cell and T‐Cell Multicentric Lymphoma in Dogs Using Serum MicroRNAs	7
Fractionated oral dosing and its effect on cyclophosphamide pharmacokinetics in dogs with high‐grade multicentric lymphoma	7
Issue Information	7
Author Index	6
	6
DNA Methylation and Its Effects on TRIM29 Gene Expression in the Equine Sarcoid Tissue	6
Issue Information	6
Use of Lomustine and Prednisolone as First‐Line Treatment in Canine Multicentric Lymphoma	6
	6
Blood Neutrophil‐to‐Lymphocyte Ratio as a Potential Prognostic Marker in Dogs ≤10 kg With Multicentric Lymphoma	6
Evaluation of serum interleukin 2 receptor and beta‐2‐microglobulin as prognostic factors for canine lymphoma: A pilot study	5
Serum Lactate Dehydrogenase as a Potential Prognostic Biomarker in Dogs With Appendicular Osteosarcoma	5
Defining the relevance of surgical margins. Part two: Strategies to improve prediction of recurrence risk	5
Comparison of the anticancer effects of various statins on canine oral melanoma cells	5
	5
Vinorelbine as a Rescue Treatment for Canine Histiocytic Sarcoma: A Multicentre Retrospective Study of 18 Dogs	5
Sodium iodide symporter immunolabelling as a predictor of clinical iodide uptake in canine thyroid carcinoma: A preliminary study	5
Prognostic impact of bone invasion in canine oral malignant melanoma treated by surgery and anti‐CSPG4 vaccination: A retrospective study on 68 cases (2010–2020)	5
Retrospective analysis of outcome and prognostic factors of subcutaneous mast cell tumours in dogs undergoing surgery with or without adjuvant treatment	5
Quantification of circulating tumour cells over time in dogs with appendicular osteosarcoma	5
Stereotactic body radiation therapy as an alternative to adrenalectomy for the treatment of pheochromocytomas in 8 dogs	5
Identification of potential plasma protein biomarkers for feline pancreatic carcinoma by liquid chromatography tandem mass spectrometry	5
Isolation of Tumour‐Derived Extracellular Vesicles From the Plasma of Dogs Affected by Intracranial Tumours Showing Heterologous and Cross‐Species Tropism: A Pilot Study	5
Evaluation of the health‐related quality of life in dogs following intracranial meningioma resection using a specifically developed questionnaire	5
Outcome in dogs with curative‐intent treatment of localized primary pulmonary histiocytic sarcoma	5
Configuration of pathologic fractures in dogs with osteosarcoma following stereotactic body radiation therapy: A retrospective analysis	5
Overactivation of Signal Transducer and Activator of Transcription 3 in Canine Hepatocellular Carcinoma and Its Prognostic Significance	5
Description and efficacy of a response‐based “QUAD” cyclical hypofractionated palliative‐intent radiation protocol in dogs with macroscopic solid tumours: 108 cases	5
Developing a translational murine‐to‐canine pathway for anIL‐2/agonistanti‐CD40antibody cancer immunotherapy	4
Impact of 10% Dose Reductions and Duration of Treatment Delays in the Management of Chemotherapy‐Induced Neutropenia in Dogs Treated With Common Chemotherapy Protocols: A Single‐Centre Experience	4
Molecular Classification Based on the Gene Expression Profiles in Canine Histiocytic Sarcoma Cells	4

Correlation between computed tomography and histological evaluation of nodal metastasis in dogs with mast cell tumours	4
A retrospective study of 101 dogs with oral melanoma treated with a weekly or biweekly 6 Gy × 6 radiotherapy protocol	4
Evaluating the relevance of surgical margins. Part one: The problems with current methodology	4
Half‐Body Radiation Therapy Results in a Prolonged Progression‐Free Interval in Canine High‐Grade Lymphoma After First Remission	4
	4
Sentinel lymph node mapping in canine mast cell tumours using a preoperative radiographic indirect lymphography: Technique description and results in 138 cases	4
Mass spectrometric‐based assessment of the serum kappa to lambda immunoglobulin light chain ratio (κ:λ) in dogs with immunoglobulin secretory diseases	4
Correction to “DNA Methylation and Its Effects on TRIM29 Gene Expression in the Equine Sarcoid Tissue”	4
VCS abstract	4
Are severe adverse events commonly observed in dogs during cancer chemotherapy? A retrospective study on 155 dogs	4
Outcome with surgical treatment of canine soft tissue sarcoma in the region of the ischiatic tuberosity: A veterinary society of surgical oncology retrospective study	4
Issue Information	4
Ovariectomy reduces the risk of tumour development and influences the histologic continuum in canine mammary tumours	4
The role of toceranib phosphate in dogs with non‐mast cell neoplasia: A systematic review	4
Evaluation of the anti‐tumour activity of Coriolus versicolor polysaccharopeptide (I'm‐Yunity) alone or in combination with doxorubicin for canine splenic hemangiosarcoma	4
Cyclical 10‐day dosing of melphalan for canine multiple myeloma	4
Immunological Pre‐Metastatic Niche in Dogs With Naturally Occurring Osteosarcoma	4
	4
Prognostic Impact of a Histologic Grading Scheme in Dogs Diagnosed With Rib Chondrosarcoma	3
Sentinel lymph node mapping with computed tomography lymphography for mast cell tumours and a comparison between regional and sentinel lymph node histological status: Sixty‐two cases	3
Newcastle disease virus LaSota strain induces apoptosis and activates the TNFα/NF‐κB pathway in canine mammary carcinoma cells	3
Prognostic significance of CD25 expression in dogs with a noninvasive diagnosis of B‐cell lymphoma treated with CHOP chemotherapy	3
	3
Characterisation of Gene Expression in Canine Invasive Urothelial Carcinoma Using a NanoString‐Based Urine Assay	3
Issue Information	3
Clinical outcomes in cats with renal carcinoma undergoing nephrectomy: A retrospective study	3
Comprehensive Analysis of the Tumour Immune Microenvironment in Canine Urothelial Carcinoma Reveals Immunosuppressive Mechanisms Induced by the COX–Prostanoid Cascade	3
A retrospective study of canine oral extramedullary plasmacytoma over a 15‐year period (July 2004–July 2019): Treatment, histologic parameters and clinical outcomes	3
Flow Cytometry for the Detection and Quantification of Mast Cells in Lymph Nodes: A Prospective Study in 64 Dogs With Mast Cell Tumour	3
Establishment and characterisation of cell lines and xenograft mouse models of canine systemic histiocytosis and disseminated histiocytic sarcoma	3
Evaluation of mechlorethamine, vinblastine, procarbazine, and prednisone for the treatment of resistant multicentric canine lymphoma	3
Exploring optical coherence tomography imaging depth to differentiate tissues at surgical margins	3
Hotspot Exon 15 Mutations in BRAF Are Uncommon in Feline Tumours	3
Increased incidence of gastrointestinal toxicity in canine cancer patients treated with concurrent abdominal radiation therapy and toceranib phosphate	3
The animal's microbiome and cancer: A translational perspective	3
Early‐Delayed Radiotoxicity Associated With Stereotactic Radiation Therapy Following a Daily 6 Gy × 5 (30 Gy) Protocol for Presumed Canine Intracranial Meningiomas	3
Establishment of a new cell line of canine inflammatory mammary cancer: IMC‐118	2
Diagnostic accuracy of optical coherence tomography for surgical margin assessment of feline injection‐site sarcoma	2
Inhibitory checkpoint molecule mRNA expression in canine soft tissue sarcoma	2
Evaluation of the Amount of Compounded Chemotherapy Drugs: A Comparison Between Nine Compounding Pharmacies	2
Surgical and oncologic outcomes in dogs with malignant peripheral nerve sheath tumours arising from the brachial or lumbosacral plexus	2
Toosendanin‐induced apoptosis of CMT‐U27 is mediated through the mitochondrial apoptotic pathway	2
Effect of Changes in Canine Thyroid Cancer Terminology on Caregiver Anxiety Levels and Treatment Preferences in a Scenario‐Based Study	2
Expression of the hedgehog signalling pathway and the effect of inhibition at the level of smoothened in canine osteosarcoma cell lines	2
Outcome and Prognostic Factors of Dogs Treated for Infiltrative Lipoma Undergoing Radiation Therapy: A Retrospective Multi‐Institutional Study of 29 Cases	2
One Health: Therapies Targeting Genetic Variants in Human and Canine Histiocytic and Dendritic Cell Sarcomas	2
Serum level of apoptosis inhibitor of macrophage in dogs with histiocytic sarcoma and its association with the disease	2
VCS 2024 Abstracts	2
Long‐term survival of dogs with stage 4 oral malignant melanoma treated with anti‐canine PD‐1 therapeutic antibody: A follow‐up case report	2
Clinical Utility of Circulating Cell‐Free DNA as a Liquid Biopsy in Cats With Various Tumours	2
Outcome of dogs with bone marrow suppression secondary to Sertoli cell tumour	2
Neurological Recovery in 14 Cats With Epidural Lymphoma Treated With Chemotherapy	2
	2
Prognostic indicators for naïve canine non‐indolent T‐cell lymphoma treated with combination lomustine, vincristine, procarbazine and prednisolone chemotherapy	2
Risk factors influencing death prior to discharge in 302 dogs undergoing unilateral adrenalectomy for treatment of primary adrenal gland tumours	2
Vincristine Induced Adverse Effects in Lymphoma Bearing Dogs With Asymptomatic Neutropenia at the Time of Drug Administration	2
Comparison of Three Chemotherapy Protocols With Electrochemotherapy for the Treatment of Feline Cutaneous Squamous Cell Carcinoma	2
CDC6: A novel canine tumour biomarker detected in circulating extracellular vesicles	2
Correction to: Standardization of canine meningioma grading: Validation of new guidelines for reproducible histopathologic criteria	2
Outcomes and prognostic factors in canine epitheliotropic and nonepitheliotropic cutaneous T‐cell lymphomas	2
Axillary lymphadenectomy in dogs: A description of surgical technique	2
Lifetime prevalence of malignant and benign tumours in companion dogs: Cross‐sectional analysis of Dog Aging Project baseline survey	2
Retrospective study evaluating the efficacy of stereotactic body radiation therapy for the treatment of confirmed or suspected primary pulmonary carcinomas in dogs	2
Safety and feasibility of short course pre‐operative radiation therapy followed by surgical excision for canine solid tumours	2
BRAF mutation status and its prognostic significance in 79 canine urothelial carcinomas: A retrospective study (2006–2019)	2
Evaluation of the therapeutic potential of masitinib and expression of its specific targets c‐Kit, PDGFR‐α, PDGFR‐β, and Lyn in canine prostate cancer cell lines	2
Issue Information	2
Precision in Parsing: Evaluation of an Open‐Source Named Entity Recognizer (NER) in Veterinary Oncology	2
Impacts of Vincristine and Prednisolone Chemotherapy on the Canine Gut Microbiota in Dogs Undergoing Treatment for Lymphoma	2
Cover Image	2
Do Pre‐Treatment Biopsy Characteristics Predict Early Tumour Progression in Feline Diffuse Large B Cell Nasal Lymphoma Treated With Radiotherapy?	2
Issue Information	2
Thromboelastographic results and hypercoagulability in dogs with surgically treated hepatocellular adenoma and carcinoma: A Veterinary Society of Surgical Oncology prospective study	2
Shear wave elastography of lymph nodes in dogs with head and neck cancer: A pilot study	2
Author Index	2
A multi‐institutional epidemiologic study evaluating environmental risk factors for feline oral squamous cell carcinoma	2
Tolerability Assessment of Orally Administered Paclitaxel With Encequidar in Dogs With Spontaneous Malignancy	1
Re‐irradiation of canine non‐lymphomatous nasal tumours using stereotactic radiation therapy (10 Gy x 3) for both courses: Assessment of outcome and toxicity in 11 dogs	1
Tumour necrosis factor stimulated gene 6 intrinsically regulates PD‐L1 expressions in breast cancer cells, leading to modulation of tumour microenvironment	1
An aggressive CD4−CD8− T‐cell neoplasm in young English bulldogs	1

Molecular and Pathobiology of Canine Mammary Tumour: Defining a Translational Model for Human Breast Cancer	1
Chemoresistance Cytological Score for Canine Transmissible Venereal Tumour: A Proposed System of Predicting Vincristine Resistance	1
New molecular targets in canine hemangiosarcoma—Comparative review and future of the precision medicine	1
Evaluation of Decreased Kidney Function in Dogs Receiving Carboplatin: A Retrospective Cohort Study of 98 Dogs (2006–2024)	1
Visualizing the cancer stem‐like properties of canine tumour cells with low proteasome activity	1
	1
	1
Evaluation of lymphocyte‐specific programmed cell death protein 1 receptor expression and cytokines in blood and urine in canine urothelial carcinoma patients	1
Clinical outcome of dogs diagnosed with canine inflammatory mammary cancer treated with metronomic cyclophosphamide, a cyclooxygenase‐2 inhibitor and toceranib phosphate	1
Calculation of dose intensity and comparison of published methods using a cohort of canine T‐cell lymphoma patients undergoing CHOP‐based chemotherapy	1
Issue Information	1
Immunohistochemical and transcriptomic characterization of T and myeloid cell infiltrates in canine malignant melanoma	1
Issue Information	1
Issue Information	1
Transferrin Receptor‐1: Expression in Canine Mammary Tumours and In Vitro Therapeutic Applications	1
Editorial	1
The association between symmetric dimethylarginine concentrations and various neoplasms in dogs and cats	1
Standardization of canine meningioma grading: Validation of new guidelines for reproducible histopathologic criteria	1
Feline primary nonhematopoietic malignant liver tumours: A multicenter retrospective study (2000–2021)	1
Immunohistochemical Expression of Programmed Death‐Ligand 1 and Cytotoxic T‐Lymphocyte Antigen‐4 in Canine Cutaneous Mast Cell Tumours	1
Macrophage Colony Stimulating Factor (M‐CSF) and Interleukin‐34 (IL‐34) Expression in Canine Osteosarcoma in the Context of the Tumour Immune Microenvironment	1
Comparative gene expression study highlights molecular similarities between triple negative breast cancer tumours and feline mammary carcinomas	1
	1
Prostaglandin EP4 receptor mRNA expression in canine lymphoma	1
Abstracts	1
Response of canine thyroid carcinomas to radioiodine	1
	1
Molecular differences in mitochondrial DNA genomes of dogs with malignant mammary tumours	1
Pilot study to evaluate isolation by size of circulating tumour cells in canine oral melanoma	1
Canine anal sac gland carcinoma with regional lymph node metastases treated with sacculectomy and lymphadenectomy: Outcome and possible prognostic factors	1
Molecular characterization of canine SHP2 mutants and anti‐tumour effect of SHP2 inhibitor, SHP099, in a xenograft mouse model of canine histiocytic sarcoma	1
The expression of histone lysine demethylase 2B in canine hemangiosarcoma is associated with disease progression	1
The prevalence of intra‐tumoral and distant thrombi, as well as tumour‐cell emboli in canine neoplasia	1
Patterns of nodal metastases, biological behaviour and prognosis of canine mast cell tumours of the pinna: A multi‐institutional retrospective study	1
Conventional fractionated radiotherapy outcomes for young dogs with nephroblastoma of the spinal cord: 5 cases	1
Patterns of metastatic progression and association with clinical outcomes in canine osteosarcoma: A necropsy study of 83 dogs	1
Allogeneic peripheral blood haematopoietic stem cell transplantation for the treatment of dogs with high‐grade B‐cell lymphoma	1
Urinary and household chemical exposures in pet dogs with urothelial cell carcinoma	1
Intraoperative assessment of canine soft tissue sarcoma by deep learning enhanced optical coherence tomography	1
Multi‐institutional retrospective study of canine foot pad malignant melanomas: 20 cases	1
Issue Information	1
Investigation of a 4.3 Gy × 10‐Fraction Volumetric Modulated Arc Therapy Protocol for Canine Prostatic Carcinoma: A Normal Tissue Complication Probability Study	1
A retrospective comparison of first and second opinion histopathology with patient outcomes in veterinary oncology cases (2011–2019)	1
Impact of palliative‐intent radiotherapy with or without chemotherapy on lameness in flat coat retrievers with localised periarticular histiocytic sarcoma – a retrospective cohort, single institution	1
Editorial	1
	1